# Synergistic Effect of Vedolizumab and Pentoxifylline

> **NCT02953275** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Miami** · enrollment: 37 (actual)

## Conditions studied

- Crohn Disease

## Interventions

- **DRUG:** vedolizumab
- **DRUG:** Pentoxifylline
- **DRUG:** placebo

## Key facts

- **NCT ID:** NCT02953275
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-04-13
- **Primary completion:** 2019-03-18
- **Final completion:** 2019-06-13
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2019-07-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02953275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02953275, "Synergistic Effect of Vedolizumab and Pentoxifylline". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02953275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*